Jiangsu Hanbon Science and Technology
688755
ZERUN CO., LTD
301636
SENXUAN
830946
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -5.25%420.36M | -5.35%1.83B | -9.29%1.38B | -15.39%922.19M | -30.65%443.64M | 11.22%1.94B | 22.71%1.52B | 27.08%1.09B | 64.21%639.69M | 6.48%1.74B |
Operating revenue | -5.25%420.36M | -5.35%1.83B | -9.29%1.38B | -15.39%922.19M | -30.65%443.64M | 11.22%1.94B | 22.71%1.52B | 27.08%1.09B | 64.21%639.69M | 6.48%1.74B |
Other operating revenue | ---- | 2.23%52.07M | ---- | -44.22%15.77M | ---- | 12.36%50.93M | ---- | 66.67%28.28M | ---- | 6.88%45.33M |
Total operating cost | -11.76%364.27M | -4.47%1.69B | -6.75%1.24B | -9.72%817.44M | -18.16%412.81M | 14.24%1.77B | 21.49%1.33B | 23.34%905.47M | 39.82%504.39M | 8.90%1.55B |
Operating cost | -2.20%175.1M | -6.64%771.93M | -9.99%578.11M | -16.80%380.36M | -33.48%179.03M | 8.47%826.85M | 15.96%642.3M | 18.23%457.16M | 54.24%269.13M | 5.79%762.31M |
Operating tax surcharges | -10.83%3.81M | -0.55%20.43M | -2.37%15.9M | -12.10%8.78M | -37.39%4.27M | 14.15%20.55M | 17.86%16.29M | 64.03%9.99M | 118.31%6.82M | 2.36%18M |
Operating expense | -27.99%85.32M | -4.21%454.01M | -8.93%323.54M | -9.96%218.11M | -4.26%118.49M | 25.63%473.95M | 31.69%355.25M | 39.71%242.23M | 31.87%123.76M | 16.92%377.26M |
Administration expense | 2.57%30.93M | 4.15%120.79M | 1.79%85.6M | 12.88%58.12M | 20.17%30.15M | 0.24%115.97M | 9.83%84.09M | 3.24%51.49M | 2.92%25.09M | 10.55%115.69M |
Financial expense | -144.48%-7.81M | -12.31%-15.7M | 24.09%-8.53M | 15.54%-10.04M | -423.08%-3.19M | 32.86%-13.98M | 53.72%-11.24M | 4.67%-11.89M | -49.65%988.19K | -477.35%-20.82M |
-Interest expense (Financial expense) | 5.83%191.55K | 16.80%754.3K | 23.97%553.33K | 23.65%348.06K | 106.36%181K | -59.16%645.79K | -56.04%446.35K | -65.71%281.49K | -82.67%87.71K | -38.75%1.58M |
-Interest Income (Financial expense) | -1.82%-2.04M | 1.20%-7.97M | -1.92%-6.09M | 9.15%-3.86M | 9.18%-2M | -72.60%-8.06M | -81.51%-5.98M | -104.76%-4.25M | -110.35%-2.2M | 35.35%-4.67M |
Research and development | -8.49%76.92M | -2.07%340.24M | 1.02%242.73M | 3.59%162.11M | 6.94%84.05M | 16.77%347.43M | 18.67%240.27M | 19.87%156.49M | 24.86%78.6M | 17.95%297.54M |
Credit Impairment Loss | -812.84%-850.36K | -676.69%-2.54M | -206.03%-538.36K | -124.36%-300.13K | 0.40%-93.16K | 138.04%441.2K | 67.40%-175.92K | 77.77%-133.77K | 63.87%-93.53K | -733.19%-1.16M |
Asset Impairment Loss | ---18.31K | -79.40%-16.34M | ---437.28K | ---437.28K | ---- | -46.01%-9.11M | ---- | ---- | ---- | 82.29%-6.24M |
Other net revenue | -3.35%7.84M | -52.84%22.15M | -43.35%28.73M | -45.73%21.72M | -60.15%8.11M | -6.53%46.97M | 5.36%50.7M | 9.70%40.03M | -6.20%20.35M | 59.87%50.25M |
Fair value change income | ---- | 41.38%-1.03M | ---- | ---- | ---- | ---1.75M | ---- | ---- | ---- | ---- |
Invest income | 569.03%998.41K | 248.83%1.8M | -46.66%655.82K | 638.37%649.09K | 47.97%-212.87K | -89.22%515.19K | -61.18%1.23M | -96.44%87.91K | -123.63%-409.12K | -34.45%4.78M |
-Including: Investment income associates | 63.45%-407.07K | 14.93%-2.11M | -419.10%-2.12M | -295.48%-1.62M | -172.21%-1.11M | -173.82%-2.48M | ---409.12K | ---409.12K | ---409.12K | -36.04%-906.36K |
Asset deal income | 902.91%25.6K | -86.13%9.65K | -95.95%2.64K | -97.47%1.65K | -77.22%2.55K | -13.61%69.59K | 10,899.46%65.12K | 10,651.93%65.12K | --11.2K | --80.56K |
Other revenue | -8.68%7.68M | -29.13%40.26M | -41.43%29.04M | -45.48%21.81M | -59.64%8.41M | 7.60%56.81M | 8.99%49.58M | 15.56%40.01M | 3.06%20.84M | -10.82%52.79M |
Operating profit | 64.12%63.92M | -23.05%164.83M | -29.86%173.51M | -43.67%126.47M | -74.98%38.95M | -11.74%214.19M | 25.23%247.36M | 40.28%224.54M | 208.17%155.65M | -0.78%242.69M |
Add:Non operating Income | 84.90%1.22M | -68.57%2.92M | 115.76%2.01M | 171.02%1.49M | 175.51%659.14K | 455.14%9.3M | -16.39%931.51K | -44.78%551.26K | -75.63%239.24K | -46.67%1.67M |
Less:Non operating expense | 146.12%65.52K | -11.72%1.82M | -37.95%390.66K | -42.85%162.29K | -74.12%26.62K | 295.57%2.06M | 150.67%629.55K | 71.81%283.95K | 26.79%102.86K | -6.36%521.46K |
Total profit | 64.41%65.08M | -25.06%165.93M | -29.29%175.13M | -43.15%127.81M | -74.59%39.58M | -9.19%221.43M | 24.83%247.67M | 39.72%224.81M | 203.03%155.79M | -1.35%243.84M |
Less:Income tax cost | -114.66%-104.65K | 2,520.45%3.09M | -75.19%2.08M | -90.06%1.38M | -95.22%713.88K | -101.14%-127.6K | -14.69%8.38M | 27.10%13.88M | 504.01%14.94M | -43.76%11.21M |
Net profit | 67.70%65.18M | -26.50%162.84M | -27.68%173.05M | -40.06%126.43M | -72.41%38.87M | -4.76%221.56M | 26.89%239.29M | 40.64%210.92M | 187.82%140.85M | 2.37%232.63M |
Net profit from continuing operation | 67.70%65.18M | -26.50%162.84M | -27.68%173.05M | -40.06%126.43M | -72.41%38.87M | -4.76%221.56M | 26.89%239.29M | 40.64%210.92M | 187.82%140.85M | 2.37%232.63M |
Less:Minority Profit | -73.70%91.78K | 186.50%729.36K | -53.40%1.15M | -65.30%1.33M | -25.01%349.03K | 182.15%254.58K | 313.49%2.47M | 951.62%3.85M | 175.44%465.45K | 92.59%-309.91K |
Net profit of parent company owners | 68.98%65.09M | -26.75%162.11M | -27.41%171.9M | -39.59%125.09M | -72.56%38.52M | -5.00%221.3M | 24.81%236.82M | 37.66%207.08M | 183.30%140.39M | 0.65%232.94M |
Earning per share | ||||||||||
Basic earning per share | 69.13%0.1123 | -26.74%0.2797 | -27.39%0.2966 | -39.59%0.2158 | -72.58%0.0664 | -5.00%0.3818 | 25.15%0.4085 | 38.02%0.3572 | 184.27%0.2422 | 0.73%0.4019 |
Diluted earning per share | 69.13%0.1123 | -26.74%0.2797 | -27.39%0.2966 | -39.59%0.2158 | -72.58%0.0664 | -5.00%0.3818 | 25.15%0.4085 | 38.02%0.3572 | 184.27%0.2422 | 0.73%0.4019 |
Other composite income | -806.83%-183.2K | 34.91%1.04M | -153.38%-1.11M | -77.20%495.03K | 102.69%25.92K | -84.25%769.08K | -57.80%2.07M | 85.18%2.17M | -1,333.96%-964.4K | 442.71%4.88M |
Other composite income of parent company owners | -848.47%-181.61K | 34.22%1.03M | -153.36%-1.11M | -77.29%492.87K | 102.52%24.26K | -84.32%767.53K | -57.96%2.07M | 84.07%2.17M | -1,353.76%-964.03K | 441.08%4.89M |
Other composite income of minority owners | -196.36%-1.59K | 376.87%7.39K | -171.25%-1.59K | 23.69%2.16K | 549.56%1.65K | 115.56%1.55K | 117.71%2.23K | 128.74%1.75K | -129.13%-368.1 | -202.57%-9.97K |
Total composite income | 67.12%65M | -26.29%163.88M | -28.76%171.94M | -40.44%126.92M | -72.20%38.89M | -6.40%222.32M | 24.74%241.36M | 40.98%213.1M | 185.40%139.89M | 5.17%237.52M |
Total composite income of parent company owners | 68.41%64.91M | -26.54%163.14M | -28.50%170.79M | -39.98%125.58M | -72.36%38.54M | -6.63%222.07M | 22.72%238.89M | 38.02%209.25M | 180.92%139.42M | 3.41%237.84M |
Total composite income of minority owners | -74.28%90.19K | 187.65%736.75K | -53.51%1.15M | -65.26%1.34M | -24.60%350.68K | 180.07%256.13K | 311.39%2.47M | 940.68%3.85M | 175.53%465.09K | 92.33%-319.87K |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.